SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'KU8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	4 / 7	HIS A 384 GLY A 385 TYR A 414 TYR A 425	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 (-3.5A)	0.37A	1dmaA-3c49A: 5.9	1dmaA-3c49A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	4 / 7	HIS A 384 TYR A 414 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-4.1A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.66A	1dmaA-3c49A: 5.9	1dmaA-3c49A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_B_NCAB700_0 (EXOTOXIN A)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	6 / 6	HIS A 384 GLY A 385 TYR A 414 ALA A 416 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.53A	1dmaB-3c49A: 5.8	1dmaB-3c49A: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAT_A_CLMA301_0 (XENOBIOTIC ACETYLTRANSFERASE)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	3 / 3	GLY A 385 TYR A 425 SER A 422	KU8 A 601 (-3.5A) KU8 A 601 (-3.5A) KU8 A 601 (-2.9A)	0.71A	2xatA-3c49A: undetectable	2xatA-3c49A: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 ALA A 416 LYS A 421 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.97A	3u9hA-3c49A: 18.8	3u9hA-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 TYR A 425	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A)	0.64A	3u9hA-3c49A: 18.8	3u9hA-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 ALA A 416 LYS A 421 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.96A	3u9hB-3c49A: 18.8	3u9hB-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 TYR A 425	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A)	0.67A	3u9hB-3c49A: 18.8	3u9hB-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	5 / 6	HIS A 384 GLY A 385 TYR A 414 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.49A	4ae1A-3c49A: 6.3	4ae1A-3c49A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	5 / 5	HIS A 384 GLY A 385 TYR A 414 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.56A	4ae1B-3c49A: 6.2	4ae1B-3c49A: 24.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 ALA A 416 LYS A 421 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.90A	4bjcA-3c49A: 17.9	4bjcA-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 TYR A 425	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A)	0.55A	4bjcA-3c49A: 17.9	4bjcA-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_A_NCAA1201_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 7	HIS A 384 GLY A 385 TYR A 414 ALA A 416 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.71A	4hyfA-3c49A: 19.5	4hyfA-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_B_NCAB1201_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	8 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.76A	4hyfB-3c49A: 19.6	4hyfB-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_C_NCAC1201_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.9A)	0.99A	4hyfC-3c49A: 19.6	4hyfC-3c49A: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_C_NCAC1201_0 (TANKYRASE-2)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 8	HIS A 384 GLY A 385 TYR A 414 ALA A 416 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.66A	4hyfC-3c49A: 19.6	4hyfC-3c49A: 23.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 11	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.9A)	0.96A	4rv6A-3c49A: 41.8	4rv6A-3c49A: 37.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 11	HIS A 384 GLY A 385 TYR A 414 ALA A 416 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.55A	4rv6A-3c49A: 41.8	4rv6A-3c49A: 37.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 11	HIS A 384 GLY A 385 TYR A 414 ALA A 416 LYS A 421 SER A 422 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-4.3A) KU8 A 601 (-2.9A) KU8 A 601 (-3.9A)	0.96A	4rv6B-3c49A: 41.9	4rv6B-3c49A: 37.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	7 / 11	HIS A 384 GLY A 385 TYR A 414 ALA A 416 SER A 422 TYR A 425 GLU A 514	KU8 A 601 (-4.0A) KU8 A 601 (-3.5A) KU8 A 601 (-4.1A) KU8 A 601 ( 4.0A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A) KU8 A 601 (-3.9A)	0.55A	4rv6B-3c49A: 41.9	4rv6B-3c49A: 37.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	5 / 9	HIS A 384 ILE A 394 TYR A 414 SER A 422 TYR A 425	KU8 A 601 (-4.0A) None KU8 A 601 (-4.1A) KU8 A 601 (-2.9A) KU8 A 601 (-3.5A)	0.48A	5ha9B-3c49A: 40.8	5ha9B-3c49A: 37.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X80_B_SALB203_1 (UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887)	3c49	POLY(ADP-RIBOSE) POLYMERASE 3 (Homo sapiens)	4 / 6	GLY A 385 TYR A 425 LEU A 399 VAL A 390	KU8 A 601 (-3.5A) KU8 A 601 (-3.5A) KU8 A 601 ( 4.5A) None	0.86A	5x80A-3c49A: undetectable 5x80B-3c49A: undetectable	5x80A-3c49A: 20.06 5x80B-3c49A: 20.06

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DMA_A_NCAA700_0","EXOTOXIN A","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",4,"HIS A 384;GLY A 385;TYR A 414;TYR A 425","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 (-3.5A)","0.37A","1dmaA-3c49A:5.9",null],["1DMA_A_NCAA700_0","EXOTOXIN A","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",4,"HIS A 384;TYR A 414;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-4.1A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.66A","1dmaA-3c49A:5.9","1dmaA-3c49A:18.36"],["1DMA_B_NCAB700_0","EXOTOXIN A","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",6,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.53A","1dmaB-3c49A:5.8","1dmaA-3c49A:18.36"],["2XAT_A_CLMA301_0","XENOBIOTIC ACETYLTRANSFERASE","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",3,"GLY A 385;TYR A 425;SER A 422","KU8 A 601 (-3.5A);KU8 A 601 (-3.5A);KU8 A 601 (-2.9A)","0.71A","2xatA-3c49A:undetectable","1dmaB-3c49A:18.36"],["3U9H_A_NCAA1163_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;ALA A 416;LYS A 421;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.97A","3u9hA-3c49A:18.8","2xatA-3c49A:19.89"],["3U9H_A_NCAA1163_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;TYR A 425","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A)","0.64A","3u9hA-3c49A:18.8","3u9hA-3c49A:23.24"],["3U9H_B_NCAB1164_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;ALA A 416;LYS A 421;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.96A","3u9hB-3c49A:18.8","3u9hA-3c49A:23.24"],["3U9H_B_NCAB1164_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;TYR A 425","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A)","0.67A","3u9hB-3c49A:18.8","3u9hB-3c49A:23.24"],["4AE1_A_NCAA1536_0","DIPHTHERIA TOXIN","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",5,"HIS A 384;GLY A 385;TYR A 414;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.49A","4ae1A-3c49A:6.3","3u9hB-3c49A:23.24"],["4AE1_B_NCAB1536_0","DIPHTHERIA TOXIN","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",5,"HIS A 384;GLY A 385;TYR A 414;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.56A","4ae1B-3c49A:6.2","4ae1A-3c49A:undetectable"],["4BJC_A_RPBA2162_1","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;ALA A 416;LYS A 421;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.90A","4bjcA-3c49A:17.9","4ae1B-3c49A:24.34"],["4BJC_A_RPBA2162_1","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;TYR A 425","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A)","0.55A","4bjcA-3c49A:17.9","4bjcA-3c49A:23.24"],["4HYF_A_NCAA1201_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.71A","4hyfA-3c49A:19.5","4bjcA-3c49A:23.24"],["4HYF_B_NCAB1201_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",8,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.76A","4hyfB-3c49A:19.6","4hyfA-3c49A:23.24"],["4HYF_C_NCAC1201_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.9A)","0.99A","4hyfC-3c49A:19.6","4hyfB-3c49A:23.24"],["4HYF_C_NCAC1201_0","TANKYRASE-2","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.66A","4hyfC-3c49A:19.6","4hyfC-3c49A:23.24"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.9A)","0.96A","4rv6A-3c49A:41.8","4hyfC-3c49A:23.24"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.55A","4rv6A-3c49A:41.8","4rv6A-3c49A:37.23"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;LYS A 421;SER A 422;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-4.3A);KU8 A 601 (-2.9A);KU8 A 601 (-3.9A)","0.96A","4rv6B-3c49A:41.9","4rv6A-3c49A:37.23"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",7,"HIS A 384;GLY A 385;TYR A 414;ALA A 416;SER A 422;TYR A 425;GLU A 514","KU8 A 601 (-4.0A);KU8 A 601 (-3.5A);KU8 A 601 (-4.1A);KU8 A 601 ( 4.0A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A);KU8 A 601 (-3.9A)","0.55A","4rv6B-3c49A:41.9","4rv6B-3c49A:37.23"],["5HA9_B_TP0B406_1","POLY [ADP-RIBOSE] POLYMERASE 1","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",5,"HIS A 384;ILE A 394;TYR A 414;SER A 422;TYR A 425","KU8 A 601 (-4.0A);None;KU8 A 601 (-4.1A);KU8 A 601 (-2.9A);KU8 A 601 (-3.5A)","0.48A","5ha9B-3c49A:40.8","4rv6B-3c49A:37.23"],["5X80_B_SALB203_1","UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887;UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887","3c49","POLY(ADP-RIBOSE) POLYMERASE 3","Homo sapiens",4,"GLY A 385;TYR A 425;LEU A 399;VAL A 390","KU8 A 601 (-3.5A);KU8 A 601 (-3.5A);KU8 A 601 ( 4.5A);None","0.86A","5x80A-3c49A:undetectable;5x80B-3c49A:undetectable","5ha9B-3c49A:37.06"]]